- Horizon has strong growth potential on its three products with significant advantages over its competitors.
- Vidara acquisition will provide tax advantages and broaden the company’s product portfolio.
- Duexis is the biggest growth contributor with a large addressable market.
- Vimovo was acquired from Astra Zeneca and caters to a similar market as Duexis.
- Expanded sales force will ensure continued growth going forward.